D-0228-2017 Class I Terminated
FDA drug recall D-0228-2017 was initiated by Town and Country Compounding and Consultation Services on August 1, 2016 and is designated Class I. Reason for recall: Non-Sterility; microbial contamination identified as Bacillus circulans The recall status is terminated (terminated October 8, 2019). Affected quantity: 12 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- December 28, 2016
- Initiation Date
- August 1, 2016
- Termination Date
- October 8, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12 vials
Product Description
Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502
Reason for Recall
Non-Sterility; microbial contamination identified as Bacillus circulans
Distribution Pattern
MA, NY, NJ & FL; Canada
Code Information
lot #07172016@1, exp 1/13/2017